Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Symptoms, Infection Duration, and Hemagglutinin Inhibition Antibody Response in Influenza A Infections

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa426Source: DataRank Database

Symptoms, Infection Duration, and Hemagglutinin Inhibition Antibody Response in Influenza A Infections is a research paper published in The Journal of Infectious Diseases (2020). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.41)OA: greenTopics (52)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Abram L. Wagner ORCID,Ángel Balmaseda ORCID,Nery Sánchez ORCID,Mayuri Patel,Roger López ORCID

Live enrichment

PubMed:32668454 PMC:PMC7938177 OpenAlex:https://openalex.org/W3043127340

National Institute for Allergy and Infectious Disease

Grant: R01 AI120997

National Institute for Allergy and Infectious Disease

Grant: HHSN272201400006C

Fogarty International Center

Grant: K02TW009483

National Institutes of Health

Grant: 7K02TW009483-04

Epidemiology and Transmission of Influenza in Nicaragua

National Institutes of Health

Grant: 3R01AI120997-04S1

Flu Dynamics COVID-19 Supplement

National Institutes of Health

FWCI

0.41

Citation Percentile

0.6%

Citation Trend

2021

2022

2024

2025

2026

greenLicense: OUP Standard Publication Reuse

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7938177

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938177

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7938177

publisherhttp://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiaa426/34134671/jiaa426.pdf

publisherhttp://academic.oup.com/jid/article-pdf/223/5/838/36448207/jiaa426.pdf

Fields of Study

Influenza Virus Research StudiesRespiratory viral infections researchHIV Research and TreatmentMedicine03 medical and health sciences0302 clinical medicineAntibodies, ViralAntibody FormationAsymptomatic InfectionsHemagglutination Inhibition TestsHemagglutinin Glycoproteins, Influenza VirusHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanNicaragua

MeSH Terms

Antibodies, ViralAntibody FormationHemagglutination Inhibition TestsHumansInfluenza, HumanNicaraguaHemagglutinin Glycoproteins, Influenza VirusInfluenza A Virus, H1N1 SubtypeAsymptomatic Infections

Keywords

AsymptomaticSerologyOdds ratioMedicineImmunologyAntibody responseAntibodyHemagglutination assayTiterConfidence intervalAntibody titerLogistic regressionInternal medicineVirologyHemagglutinin (influenza)AntibodiesInfluenza A VirusHemagglutination Inhibition TestsSigns And SymptomsInfectious Disease TransmissionInfluenza A Virus, H1N1 SubtypeAntibody FormationInfluenza, HumanHumansHemagglutinin Glycoproteins, Influenza VirusNicaraguaAntibodies, ViralAsymptomatic Infections

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being